Pancreatic Cancer Trial, Recruiting NCT01102556 Sponsor: Columbia University Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT01102556
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been diagnosed with pancreatic cancer, are suspected of having pancreatic cancer, or have a pre-cancerous growth in the pancreas
  • Adults aged 18 or older who have had two or more cancers linked to a condition called hereditary nonpolyposis colorectal cancer (HNPCC), which includes cancers of the colon, uterus, small bowel, liver/bile ducts, pancreas, urinary tract, or stomach (confirm with trial site)
  • Adults aged 18 or older with colon cancer and a close family member (parent, sibling, or child) who had an HNPCC-related cancer or colon polyp, where one of those was diagnosed before age 45 and the polyp before age 40 (confirm with trial site)
  • Adults aged 18 or older diagnosed with colon or uterine cancer before age 50
  • Adults aged 18 or older diagnosed before age 45 with a specific type of colon cancer on the right side of the colon, or with a certain type of colon polyp diagnosed before age 40 (confirm with trial site)
  • Adults aged 18 or older with a personal or family history of conditions linked to a higher risk of pancreatic cancer, such as Peutz-Jeghers syndrome, familial pancreatic cancer, inherited breast cancer gene mutations (BRCA-1 or BRCA-2), hereditary pancreatitis, or familial atypical multiple mole melanoma, among others
  • Adults aged 18 or older who belong to a family with a known inherited cancer condition
  • Adults aged 18 or older who have personally had a gastrointestinal (digestive system) cancer diagnosed before age 45
  • Adults aged 18 or older with a personal or family history that suggests a higher risk of pancreatic cancer, including: a personal history of pancreatic cancer or a pre-cancerous pancreatic growth; a family history of two or more people with cancer where at least one had a digestive system cancer; a family member or personal history of digestive system cancer diagnosed before age 50; or a history of more than one cancer diagnosis where at least one involved the digestive system

Who may not be able to join:

  • People who are unable to give informed consent to participate in the study
  • People under the age of 18

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Beth Schrope, MD, PhD, FACS, Columbia University

Phone: 212-305-6033

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2004
Est. completion
1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Creation of a registry and blood/tissue bank

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov